BRENNER RANDALL B. (Chief Development & Regulatory) sold 1.3% of their position (4.54K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $9.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/22/2022ACC: 0000904454-22-000649
Officer· Chief Development & Regulatory
Since Sep 2019
+10.46K
Net shares
Net buyer
$9.0K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
15K acquired · 4.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15K
Price / share
—
Trade value
—
% of position
4.6%
12/20/2022
324.85K→339.85K
Common Stock
Direct
Shares
−4.54K
Price / share
$1.99
Trade value
$9.03K
% of position
1.3%
12/21/2022
339.85K→335.31K
Total
Net shares
+10.46K
Net value
-$9.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/20/2022 | A · Award | +15K | — | — | 4.6% | 324.85K | 339.85K |
| Common Stock Direct | 12/21/2022 | S · Sale | −4.54K | $1.99 | $9.03K | 1.3% | 339.85K | 335.31K |
| Total | +10.46K | -$9.03K | ||||||
Derivative Transactions0
No derivative transactions reported